Products

Get a quote

We're excited to learn more about your project and provide you with a customized quote tailored to your needs. Please fill out the form below, and we'll get back to you as soon as possible.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Rabbit Anti-Monkeypox Virus A27L Polyclonal Antibody

Cat. No.VD11Y659

Product TypeVeterinary Antibodies

Size

Inquiry Now Add to Inquiry List

Product Overview

BioVenic rabbit anti-monkeypox virus A27L polyclonal antibody can be used in ELISA and WB to help researchers detect or develop diagnosis assays of monkeypox virus infection.

Specifications

Application ELISA,WB

Clonality Polyclonal Antibody

Classification Primary Antibody

Clone N29Y99

Host Rabbit

Target Species Virus

Species Reactivity Virus

Specificity Monkeypox Virus A27L

Isotype IgG

Immunogen Recombinant Monkeypox virus A27L.

Conjugation Unconjugated

Preservative and Stabilizer 0.05% ProClin 300, 50% Glycerol

Buffer 1X Phosphate buffered saline, pH 7.4

Physical State Liquid

Target Information

The monkeypox virus (MPXV) A-type inclusion protein, encoded by the A27L gene, is involved in the formation of characteristic viral inclusion bodies. Diagnostic tests targeting the A27L inclusion protein can facilitate early detection of the monkeypox virus and benefit animal and human health.

Target Monkeypox Virus A27L

Target Synonym A-type inclusion protein

UniProt ID A0A0F7G8M1

Shipping and Storage

This product is shipped with dry ice. Store at -20°C to -80°C on receipt (up to 12 months). Avoid repeated freezing and thawing as this may denature the antibody.

Documents

Datasheet

COA

To request a Certificate of Analysis, please enter the Lot No. in the search box. Note: Certificate of Analysis not available for kits.

The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.

References

Pacchioni, Sole Maria, et al. "L1R, A27L, A33R and B5R vaccinia virus genes expressed by fowlpox recombinants as putative novel orthopoxvirus vaccines." Journal of translational medicine 11 (2013): 1-10.